Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry - Test2 - elhamkhani - TriplyDB

Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry

Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry

http://www.wikidata.org/entity/Q33827116

about

Systolic heart failure: knowledge gaps, misconceptions, and future directions New horizon for infection prevention technology and implantable device The subcutaneous ICD-current evidence and challenges 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the [Primary and secondary prophylactic ICD therapy in congenital electrical and structural cardiomyopathies].Oversensing of atrial fibrillatory waves in a subcutaneous implantable cardioverter-defibrillator.T-wave oversensing during drug challenge test after subcutaneous implantable cardioverter-defibrillator implantation in a patient with Brugada syndrome Systemic infection due to subcutaneous implantable cardioverter-defibrillator implantation: Importance of early recognition and treatment of device pocket-related complications Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator.Recent advances in the management of ventricular tachyarrhythmias.Early experience with the subcutaneous ICD.The entirely subcutaneous defibrillator (s-icd): state of the art and selection of the ideal candidate Successful Implant of a Subcutaneous ICD System in a Patient with an Ipsilateral Epicardial Pacemaker Recent advances in the entirely subcutaneous ICD System.Initial experience of subcutaneous implantable cardioverter defibrillators in Singapore: a case series and review of the literature Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience.Transvenous Implantable Cardioverter-Defibrillator (ICD) Lead Performance: A Meta-Analysis of Observational Studies.Clinical and electrocardiographic predictors of T wave oversensing in patients with subcutaneous ICD.The learning curve associated with the introduction of the subcutaneous implantable defibrillator.Intraoperative Defibrillation Testing of Subcutaneous Implantable Cardioverter-Defibrillator Systems-A Simple Issue?Electrophysiology Updates in Adult Congenital Heart Disease.Trends and In-Hospital Outcomes Associated With Adoption of the Subcutaneous Implantable Cardioverter Defibrillator in the United States.Management of Cardiac Electronic Device Infections: Challenges and Outcomes.Inappropriate shocks from a subcutaneous implantable cardioverter-defibrillator due to oversensing during periods of rate-related bundle branch block Sudden cardiac death and obesity.Development of the subcutaneous implantable cardioverter-defibrillator for reducing sudden cardiac death.Subcutaneous implantable cardiac defibrillators: indications and limitations.The year in cardiology 2014: arrhythmias and device therapy.Infected cardiac-implantable electronic devices: prevention, diagnosis, and treatment.Controlled sedation with midazolam and analgesia with nalbuphine to alleviate pain in patients undergoing subcutaneous implantable cardioverter defibrillator implantation.The subcutaneous implantable cardioverter and defibrillator: advantages, limitations and future directions.When to consider an implantable cardioverter defibrillator following myocardial infarction?Implantable cardioverter defibrillator management: an update.Where is the future of cardiac lead extraction heading?Characteristics and early clinical outcomes of patients undergoing totally subcutaneous vs. transvenous single chamber implantable cardioverter defibrillator placement.The Role of Conventional and Right-Sided ECG Screening for Subcutaneous ICD in a Tetralogy of Fallot Population.Heart Failure With Reduced Ejection Fraction And A Narrow QRS Complex: Combination Of A Subcutaneous Defibrillator With Cardiac Contractility Modulation.The Italian subcutaneous implantable cardioverter-defibrillator survey: S-ICD, why not?The Design of the Understanding Outcomes with the S-ICD in Primary Prevention Patients with Low EF Study (UNTOUCHED).Long-time "real-life" performance of the subcutaneous ICD in patients with electrical heart disease or idiopathic ventricular fibrillation.

P2860

Q27024573-7BD0BEA8-9051-47B0-ABDD-238E2BF8C58C Q28080257-6D442E6F-41A9-43AE-A649-C6D28A64DBC9 Q28081629-CF151080-4BCC-4583-A41D-D845F819AAB3 Q28087002-15E8992B-9AE2-4234-9420-65A36652DCB1 Q33165762-55832F9F-EEF4-4078-8668-346ACA518F9C Q33643841-69D0AC5C-A98E-4CE2-B688-DC1EA5A0743D Q33644226-245B6559-7B6F-41D2-A13B-D7D88656AFA1 Q33644432-912C38A7-961C-4530-95FB-2107179B49C3 Q33792627-CEE63844-8865-4540-A710-4D62C96E5192 Q33873348-1F53A4A4-B34E-48A9-9AA9-7424BA177E9D Q33990830-E5F9BF51-5EAE-45AB-B505-7B04F9DDCC89 Q35168789-63A7DCB9-04B7-4D33-A805-9BA92CF2919D Q35235981-9DFE6188-A938-4C59-BBE1-8096B287A1C5 Q35659336-A356DD34-EB0E-4849-9819-58DDC04D8F56 Q36186091-DFAA7181-AAF7-4142-9274-810C54BEFD80 Q36714053-CFA24BA1-26B7-44A7-989C-ADB72F955623 Q36836212-BDDE857D-FF24-4862-BE18-679DA8D936D9 Q37019042-C0C29D07-E2CA-4072-850C-911A22B03518 Q37052285-C0749C88-DAE7-4661-B4F5-FD1EBC98C1C9 Q37090875-E9FC93BB-D1B5-49C8-899D-5F310EE5F676 Q37344566-E4CCEC26-5402-42DB-BB7E-10EAE08833C5 Q37418526-35C4A06F-0698-42ED-80A0-62C63E8A6DB1 Q37596061-0C29ED30-428C-4540-A89B-41D862A69E6E Q37634475-6040F610-4D1F-4C4D-AD7C-8D7C9A920E6B Q38243742-D104C168-CEE5-48C4-9F8E-6FF135D99B76 Q38259509-62A7DB8B-5E5E-44CB-8BAF-D72506491D78 Q38283135-33DE544A-06E7-4D72-9D94-7B89215C3F9D Q38307425-75044FBC-C5E6-419E-B9DC-6F05970C2A2A Q38370148-99DCB4DD-7A7B-41C1-978D-D12AF8537636 Q38431054-C1F975E4-C7DC-4F45-B719-209A4D77755D Q38574178-F60954BA-D13F-4EF2-832B-ED441C78AC9F Q38622827-4EC8935B-FD91-4AC3-95FA-C29992AEF750 Q38801619-0E90D549-98C3-4268-991F-671EF4BFB427 Q38834180-6F356E52-B377-4D6D-973B-30ADE85DF059 Q38850348-62D9D73D-3521-47A9-AD7F-8DA83A417AC6 Q39029938-9EEB5877-39C6-41E7-A486-3602A51638F1 Q39037129-61F5CB33-B498-4D01-A704-62DBE4C767B4 Q39067494-60A4CD97-2427-467C-BB4C-867BBED3D0FE Q39108868-63856D0D-8AEB-435A-9EA7-A86A2007ABE5 Q39741721-1478AA95-DCFB-4A1D-A461-8D3C52EED173

P2860

Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry

http://www.wikidata.org/entity/Q33827116

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Worldwide experience with a to ...... the EFFORTLESS S-ICD Registry

@ast

Worldwide experience with a to ...... the EFFORTLESS S-ICD Registry

@en

type

label

Worldwide experience with a to ...... the EFFORTLESS S-ICD Registry

@ast

Worldwide experience with a to ...... the EFFORTLESS S-ICD Registry

@en

prefLabel

Worldwide experience with a to ...... the EFFORTLESS S-ICD Registry

@ast

Worldwide experience with a to ...... the EFFORTLESS S-ICD Registry

@en

P1433

Q33827116-5D5F3B61-6EDA-4574-B5C8-649E8B422278

P1476

Q33827116-5AC42D4C-E8CB-4092-AF81-F6ADA1E81990

P2093

Q33827116-05F80198-0CC3-4665-8074-31157308BE5F

Q33827116-14FF7B05-B62C-4C14-A6C6-1275E62493AB

Q33827116-1E16EBE5-BA37-4285-B59F-D896C6B78BF1

Q33827116-2C5498AD-366A-41F0-9D78-1249A76DECFA

Q33827116-68562020-A498-4A1B-B509-28AFE4768CBD

Q33827116-69EF0A83-CDCA-4420-8485-7713BF7B5C85

Q33827116-6F306BF8-9AD3-447D-945D-CBAED3E323FE

Q33827116-7C03A8DD-0F27-4C0A-9837-13C2F5AAC56A

Q33827116-85BD5862-787E-4C23-9CD6-5196BB94A0C6

Q33827116-978C9EFC-EF36-4CCA-93B4-256A58A445D6

P2860

Q33827116-06F387C7-E82B-40DB-9066-474F318A84EA

Q33827116-0F9C3406-D95F-454C-B4AA-9D3E37FA00EC

Q33827116-125FB142-F731-4E03-B635-0A7D04B272A5

Q33827116-12847911-4334-4FD5-B13E-1A5D3D049912

Q33827116-1D20741B-7C3F-497D-B925-E8F7E0CC6B32

Q33827116-1E77961A-BA5F-428B-BC1E-862027912D13

Q33827116-1EB29CC9-9594-4554-BD51-269344E54D42

Q33827116-2153454E-0BAF-4FFB-8EB9-C509B1AC46C9

Q33827116-3F088640-E084-43C8-A603-99CA70BE27DE

Q33827116-4780E2AB-1595-48F2-95BA-9498E9F6D0E3

P304

Q33827116-D3655217-1C37-4CCD-A653-EB58F1BC36DC

P31

Q33827116-74AAF436-E04B-45EA-A5C9-A87544B87618

P356

Q33827116-CBB2FD43-224A-4EE7-A5D9-E191F86328AC

P433

Q33827116-BA261308-AC9A-4420-B793-5ACFA98A83D5

P478

Q33827116-A1981987-C564-4BD2-B830-3B562995CC50

P50

Q33827116-75A1679D-7936-4D56-9E74-EE6C20FE9AE8

Q33827116-FD720045-85E9-4CE1-81E8-0854F255B156

P577

Q33827116-6BEEE7BA-82D4-4B0E-AF46-3D109F625042

P5875

Q33827116-4FC9969F-B525-445D-8422-34599431D4F4

P698

Q33827116-4928036A-13B8-423D-AC78-1E187705F907

P921

Q33827116-347BB3A7-B107-4A6D-A476-6489DEB6BE0C

P932

Q33827116-986694A5-14A3-4D14-BE35-7C1F0E34F6E3

P356

P1433

European Heart Journal

P1476

Worldwide experience with a to ...... the EFFORTLESS S-ICD Registry

@en

P2093

Craig Barr

http://www.w3.org/2001/XMLSchema#string

Dominic A M J Theuns

http://www.w3.org/2001/XMLSchema#string

EFFORTLESS Investigators

http://www.w3.org/2001/XMLSchema#string

Francis Murgatroyd

http://www.w3.org/2001/XMLSchema#string

Helen L Reeve

http://www.w3.org/2001/XMLSchema#string

Jens Brock Johansen

http://www.w3.org/2001/XMLSchema#string

Lucas Boersma

http://www.w3.org/2001/XMLSchema#string

Margaret Hood

http://www.w3.org/2001/XMLSchema#string

Nathan Carter

http://www.w3.org/2001/XMLSchema#string

Petr Neuzil

http://www.w3.org/2001/XMLSchema#string

P2860

Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Ther

Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure.

An entirely subcutaneous implantable cardioverter-defibrillator.

Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings.

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years.

P304

1657-1665

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHU112

http://www.w3.org/2001/XMLSchema#string

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

Susanne S Pedersen

Pier D. Lambiase

P577

2014-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261138146

http://www.w3.org/2001/XMLSchema#string

P698

24670710

http://www.w3.org/2001/XMLSchema#string

P921

P932

4076663

http://www.w3.org/2001/XMLSchema#string